Millennium Management
ALZN icon

Millennium Management’s Alzamend Neuro ALZN Stock Holding History

Millennium Management’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$6.55K – 6034
2023
Q3 		$6.55K Buy
+20
New +$9.56K ﹤0.01% 5835
2022
Q3 		– Sell
-36
Closed -$43K – 7030
2022
Q2 		$43K Sell
36
-69
-66% -$89.4K ﹤0.01% 6246
2022
Q1 		$175K Buy
105
+95
+950% +$178K ﹤0.01% 5883
2021
Q4 		$26K Buy
+10
New +$30.9K ﹤0.01% 6585

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Millennium Management's ALZN Position: Q4 2023 in Review

Millennium Management sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 20 shares — an estimated $6.55K sold.

Millennium Management first reported a position in ALZN in Q4 2021 and held it in 4 quarters. The position peaked at $175K in Q1 2022. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Millennium Management reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 20 Alzamend Neuro shares in Q4 2023, an estimated $6.55K.
  • Millennium Management first reported a position in Alzamend Neuro in Q4 2021 and held it in 4 quarters.
  • Millennium Management's Alzamend Neuro position peaked at $175K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.